ARTICLE | Company News
Cognition names Moch CEO
October 28, 2016 7:00 AM UTC
Neuroscience therapeutics company Cognition Therapeutics Inc. (Pittsburgh, Pa.) hired Kenneth Moch as president and CEO, replacing Hank Safferstein. Moch, who was managing partner of consulting firm Salutramed Group, was president and CEO of Chimerix Inc. (NASDAQ:CMRX). ...